삼성서울병원

Ko En

Seol, Ho Jun M.D

TITLE
Professor, Department of neurosurgery, Samsung Medical Center, Sungkyunkwan university School of Medicine
Treament Schedule 12 月
DATE
SUN
01
MON
02
TUE
03
WEB
04
THU
05
FRI
06
SAT
07
SUN
08
MON
09
TUE
10
WEB
11
THU
12
FRI
13
SAT
14
SUN
15
MON
16
TUE
17
WEB
18
THU
19
FRI
20
SAT
21
SUN
22
MON
23
TUE
24
WEB
25
THU
26
FRI
27
SAT
28
SUN
29
MON
30
TUE
31
AM
PM
Treament Schedule 01 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM

Medical School

Seoul National University College of Medicine

Specialty Training

Fellowship   Brain tumor & stereotactic surgery, Seoul National University Hospital
Labatt Brain Tumor Research Center, Toronto University, Hospital for Sick Children, Canada
Residency   Seoul National University Hospital
Internship   Seoul National University Hospital

Other Education

Labatt Brain Tumor Research Center, Hospital for Sick Children, University of Toronto, Canada

Participation in Academic Societies
and Research

Executive secretary for Korean Brain Tumor Society
Member of Korean Society of Neuro-Oncology
Member of Korean Society of Pediatric Neurosurgery
Member of Korean Brain Tumor Society

Selected Publications

  • Nat Genet. 2017 Apr;49(4):594-599. doi: 10.1038/ng.3806. Epub 2017 Mar 6. Spatiotemporal genomic architecture informs precision oncology in glioblastoma Lee JK11,2, Wang J3,4,5, Sa JK1,2,6, Ladewig E3,4, Lee HO7, Lee IH1,2, Kang HJ1,2, Rosenbloom DS3,4, Camara PG3,4, Liu Z3,4, van Nieuwenhuizen P3,4, Jung SW1,2,6, Choi SW1,2,6, Kim J1,2, Chen A3,4, Kim KT7, Shin S1,2,6, Seo YJ1,2, Oh JM1,2, Shin YJ1,2,7, Park CK8, Kong DS2, Seol HJ2, Blumberg A9, Lee JI2, Iavarone A10,11,12, Park WY6,7, Rabadan R3,4, Nam DH1,2,6.
    View PubMed
  • Cancer Res Treat. 2017 Jan;49(1):193-203. doi: 10.4143/crt.2015.473. Epub 2016 Jun 27. Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea Kim BS11, Seol HJ2, Nam DH2, Park CK3, Kim IH4, Kim TM5, Kim JH6, Cho YH6, Yoon SM7, Chang JH8, Kang SG8, Kim EH8, Suh CO9, Jung TY10, Lee KH11, Kim CY12, Kim IA13, Hong CK14, Yoo H15, Kim JH16, Kang SH17, Kang MK18, Kim EY19, Kim SH20, Chung DS21, Hwang SC22, Song JH23, Cho SJ24, Lee SI25, Lee YS26, Ahn KJ27, Kim SH28, Lim DH29, Gwak HS30, Lee SH31, Hong YK32.
    View PubMed
  • J Clin Neurosci. 2017 Jan;35:35-41. doi: 10.1016/j.jocn.2016.10.002. Epub 2016 Oct 18. Gamma knife radiosurgery for residual or recurrent intracranial hemangiopericytomas Kim BS11, Kong DS2, Seol HJ2, Nam DH2, Lee JI3.
    View PubMed
  • J Korean Neurosurg Soc. 2017 Jan 1;60(1):21-29. doi: 10.3340/jkns.2016.0404.005. Epub 2016 Dec 29. The Influence of Biomarker Mutations and Systemic Treatment on Cerebral Metastases from NSCLC Treated with Radiosurgery Lee MH11, Kong DS1, Seol HJ1, Nam DH1, Lee JI1.
    View PubMed
  • Cancer Med. 2016 Dec;5(12):3615-3621. doi: 10.1002/cam4.955. Epub 2016 Nov 23. Analysis of risk factors to predict communicating hydrocephalus following gamma knife radiosurgery for intracranial schwannoma Lee S11, Seo SW2, Hwang J1, Seol HJ1, Nam DH1, Lee JI1, Kong DS1.
    View PubMed